Your browser doesn't support javascript.
loading
Treating Opioid Use Disorder With a Monthly Subcutaneous Buprenorphine Depot Injection: 12-Month Safety, Tolerability, and Efficacy Analysis.
Andorn, Anne C; Haight, Barbara R; Shinde, Sunita; Fudala, Paul J; Zhao, Yue; Heidbreder, Christian; Learned, Susan M; Fox, Norma Lynn; Nadipelli, Vijay R; Hassman, David; Rutrick, Daniel.
Afiliação
  • Andorn AC; From Indivior Inc., North Chesterfield, VA.
  • Haight BR; From Indivior Inc., North Chesterfield, VA.
  • Shinde S; From Indivior Inc., North Chesterfield, VA.
  • Fudala PJ; From Indivior Inc., North Chesterfield, VA.
  • Zhao Y; From Indivior Inc., North Chesterfield, VA.
  • Heidbreder C; From Indivior Inc., North Chesterfield, VA.
  • Learned SM; From Indivior Inc., North Chesterfield, VA.
  • Fox NL; From Indivior Inc., North Chesterfield, VA.
  • Nadipelli VR; From Indivior Inc., North Chesterfield, VA.
  • Hassman D; Comprehensive Clinical Research, Berlin, NJ.
  • Rutrick D; Adams Clinical, Watertown, MA.
J Clin Psychopharmacol ; 40(3): 231-239, 2020.
Article em En | MEDLINE | ID: mdl-32282418
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Buprenorfina / Transtornos Relacionados ao Uso de Opioides Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Buprenorfina / Transtornos Relacionados ao Uso de Opioides Idioma: En Ano de publicação: 2020 Tipo de documento: Article